Resources to Improve Acute Kidney Injury Care

Study Lead

Dr. Peter Birks and Dr. Michelle Wong

University of British Columbia

Overview

Acute kidney injury (AKI) occurs when kidney function rapidly declines, and it affects up to 20% of patients in hospital. AKI is related to increased risk of death, higher healthcare costs and other harmful heath occurrences. After an episode of AKI, there are interventions that can improve outcomes but there is a recognized gap in the delivery of optimal post-AKI care.

Have you or someone you know experienced acute kidney injury (AKI) ? We would like to get your feedback on resources we have developed for both patients and family physicians to improve AKI care. The resources include a patient flyer, a webpage on AKI, and a discharge summary.

Participant Commitment: You can provide your feedback on these resources over a 1-2 hour virtual focus group. Providing feedback via email or phone call can be done if your schedule is tight but you would like to participate.

Eligibility

Patients over the age of 19 who have had diagnosed with AKI at some point in their medical history, or caregivers and family members of someone who has.

Type of Participation

Focus Group, Interview

Diagnosis

Acute Kidney Injury

Location

British Columbia

Related studies

  • Promoting shared decision making for people with advanced chronic kidney disease

    Overview:

    Study type: Focus Group

    August 8, 2024

  • Improving the Care and Experiences of Living Kidney Donors

    Overview: Seeking family physicians and transplant healthcare professionals for an online interview that will help develop tools to improve the experiences, care, and outcomes of living kidney donors.

    Study type: Interview

    July 25, 2024

  • Phase 3 Pneumococcal Vaccine Study for Children & Adolescents at High Risk (STRIDE-13)

    Overview: STRIDE-13 is a pneumococcal vaccine research trial for children and adolescents with chronic disease (or chronic medical conditions).

    Study type: Clinical Trial

    July 11, 2024